Hartland & Co »

Acelyrin shares owned by Hartland & Co

Quarter-by-quarter ownership of Acelyrin (SLRN) shares owned by Hartland & Co from 13F filings

Historical chart of Hartland & Co investment in Acelyrin

Tip: Access up to 7 years of quarterly data

All positions including Acelyrin held by Hartland & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acelyrin by Hartland & Co

Quarter filed Position value Share count Share price at filing
2024-09-30 $563 114 4.94
2024-06-30 $503 114 4.41

More positions owned by Hartland & Co

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Rus 1000 Grw Etf (IWF)
Apple (AAPL)
Vanguard Index Fds Mid Cap Etf (VO)
Microsoft Corporation (MSFT)
Vanguard Index Fds Small Cp Etf (VB)
Vanguard Index Fds Value Etf (VTV)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Ishares Tr Msci Usa Qlt Fct (QUAL)
J P Morgan Exchange Traded F Equity Premium (JEPI)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
Norfolk Southern (NSC)
Ishares Tr Us Treas Bd Etf (GOVT)
Ishares Tr Rus Mid Cap Etf (IWR)

View all positions for Hartland & Co

Top funds holding Acelyrin

T. Rowe Price Investment Management
AyurMaya Capital Management Company
Citadel Advisors
BlackRock
BlackRock
Vanguard Group
OrbiMed Advisors
venBio Partners
General Atlantic
Blue Owl Capital Holdings
Samsara BioCapital
Opaleye Management
Palo Alto Investors
Siren
Geode Capital Management

View all funds holding Acelyrin